Ospedale Sandro Pertini, Roma Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2010
NCT04753775
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ospedale Sandro Pertini, Roma | UOC pediatria Hospital "Sandro Pertini"

Active Ingredients

Drugs in Phase 3 Trials (2)

interferon alpha-2b (Intron-A) (1 trial)

ribavirin (virazole) (1 trial)

Drugs in Other Trials (1)

aloe vera (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis, Chronic (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3